BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Secker GA, Harvey NL. Regulation of VEGFR Signalling in Lymphatic Vascular Development and Disease: An Update. Int J Mol Sci 2021;22:7760. [PMID: 34299378 DOI: 10.3390/ijms22147760] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao L, Teng Q, Liu Y, Chen H, Chong W, Du F, Xiao K, Sang Y, Ma C, Cui J, Shang L, Zhang R. Machine learning-based identification of a novel prognosis-related long noncoding RNA signature for gastric cancer. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1017767] [Reference Citation Analysis]
2 Huynh MT, Degre S, Joly-Helas G, Bréon C, Potel S, Chambon P, Bouligand J, Layet V. Heterozygous deletion of the VEGFC gene in 4q34.3 is associated with Milroy-like lymphedema: First prenatal case report. Am J Med Genet A 2022. [PMID: 36129367 DOI: 10.1002/ajmg.a.62973] [Reference Citation Analysis]
3 Yu L, Wang Y, He Y, Zhong H, Ge S, Zou Y, Lai Y, Xu Q, Gao J, Liu W, Guo W. Combination of apatinib with apo-IDO1 inhibitor for the treatment of colorectal cancer. Int Immunopharmacol 2022;112:109233. [PMID: 36126409 DOI: 10.1016/j.intimp.2022.109233] [Reference Citation Analysis]
4 Bolatai A, He Y, Wu N. Vascular endothelial growth factor and its receptors regulation in gestational diabetes mellitus and eclampsia. J Transl Med 2022;20:400. [PMID: 36064413 DOI: 10.1186/s12967-022-03603-4] [Reference Citation Analysis]
5 Luo X, Zou W, Wei Z, Yu S, Zhao Y, Wu Y, Wang A, Lu Y. Inducing vascular normalization: A promising strategy for immunotherapy. Int Immunopharmacol 2022;112:109167. [PMID: 36037653 DOI: 10.1016/j.intimp.2022.109167] [Reference Citation Analysis]
6 Canto LM, da Silva JM, Castelo-branco PV, da Silva IM, Nogueira L, Fonseca-alves CE, Khayat A, Birbrair A, Pereira SR. Mutational Signature and Integrative Genomic Analysis of Human Papillomavirus-Associated Penile Squamous Cell Carcinomas from Latin American Patients. Cancers 2022;14:3514. [DOI: 10.3390/cancers14143514] [Reference Citation Analysis]
7 Bonetti G, Paolacci S, Samaja M, Maltese PE, Michelini S, Michelini S, Michelini S, Ricci M, Cestari M, Dautaj A, Medori MC, Bertelli M. Low Efficacy of Genetic Tests for the Diagnosis of Primary Lymphedema Prompts Novel Insights into the Underlying Molecular Pathways. IJMS 2022;23:7414. [DOI: 10.3390/ijms23137414] [Reference Citation Analysis]
8 Kim B, Choi DY, Kim M, Jang A, Suh M, Lee JH, Oh SH, Park MK. Effect of Angiogenesis and Lymphangiogenesis in Diesel Exhaust Particles Inhalation in Mouse Model of LPS Induced Acute Otitis Media. Front Cell Infect Microbiol 2022;12:824575. [DOI: 10.3389/fcimb.2022.824575] [Reference Citation Analysis]
9 Zhou J, Hu Y, Zhu W, Nie C, Zhao W, Faje AT, Labelle KE, Swearingen B, Lee H, Hedley-whyte ET, Zhang X, Jones PS, Miller KK, Klibanski A, Zhou Y, Soberman RJ. Sprouting Angiogenesis in Human Pituitary Adenomas. Front Oncol 2022;12:875219. [DOI: 10.3389/fonc.2022.875219] [Reference Citation Analysis]
10 Wang C, Chu M. Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis. Front Oncol 2021;11:783309. [PMID: 35087755 DOI: 10.3389/fonc.2021.783309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Brown S, Dayan JH, Coriddi M, Campbell A, Kuonqui K, Shin J, Park HJ, Mehrara BJ, Kataru RP. Pharmacological Treatment of Secondary Lymphedema. Front Pharmacol 2022;13:828513. [DOI: 10.3389/fphar.2022.828513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 He Y, Deng P, Yan Y, Zhu L, Chen H, Li T, Li Y, Li J. Matrisome provides a supportive microenvironment for oral squamous cell carcinoma progression. J Proteomics 2021;253:104454. [PMID: 34922012 DOI: 10.1016/j.jprot.2021.104454] [Reference Citation Analysis]
13 Natale G, Stouthandel MEJ, Van Hoof T, Bocci G. The Lymphatic System in Breast Cancer: Anatomical and Molecular Approaches. Medicina 2021;57:1272. [DOI: 10.3390/medicina57111272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Blei F. Update October 2021. Lymphat Res Biol 2021;19:488-512. [PMID: 34610248 DOI: 10.1089/lrb.2021.29111.fb] [Reference Citation Analysis]
15 Chen X, Hu QY, Wang M, Jia J, Teng J, Sun Y, Cheng X, Ye J, Su Y, Shi H, Chi H, Zhou Z, Liu T, Wang Z, Wan L, Qiao X, Wang F, Wu X, Yang C, Liu HL. Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease. Rheumatol Int 2021. [PMID: 34499196 DOI: 10.1007/s00296-021-04978-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]